MoneyWorks4Me

Concord Biotech - Quaterly Results

30 May 2026 Evaluate
A decrease in the sales to Rs. 3258.92 millions was observed for the quarter ended March 2026. The sales stood at Rs. 4298.84 millions during the similar quarter previous year.A big decline of -36.58% was reported for the quarter ended March 2026 to Rs. 900.22  millions from Rs. 1419.37 millions of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 1379.23 millions from 1998.07 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3258.92 4298.84 -24.19 10550.71 12000.87 -12.08 10550.71 12000.87 -12.08
Other Income 155.42 93.84 65.62 527.31 444.47 18.64 527.31 444.47 18.64
PBIDT 1379.23 1998.07 -30.97 4292.66 5507.79 -22.06 4292.66 5507.79 -22.06
Interest 0.58 0.96 -39.58 2.34 5.29 -55.77 2.34 5.29 -55.77
PBDT 1378.65 1997.11 -30.97 4257.57 5502.50 -22.62 4257.57 5502.50 -22.62
Depreciation 194.87 146.17 33.32 743.25 543.74 36.69 743.25 543.74 36.69
PBT 1183.78 1850.94 -36.04 3514.32 4958.76 -29.13 3514.32 4958.76 -29.13
TAX 283.56 431.57 -34.30 881.65 1229.11 -28.27 881.65 1229.11 -28.27
Deferred Tax -2.93 13.42 -121.83 18.74 39.50 -52.56 18.74 39.50 -52.56
PAT 900.22 1419.37 -36.58 2632.67 3729.65 -29.41 2632.67 3729.65 -29.41
Equity 104.62 104.62 0.00 104.62 104.62 0.00 104.62 104.62 0.00
PBIDTM(%) 42.32 46.48 -8.95 40.69 45.89 -11.35 40.69 45.89 -11.35
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..